vs

Side-by-side financial comparison of RadNet, Inc. (RDNT) and Trade Desk (The) (TTD). Click either name above to swap in a different company.

Trade Desk (The) is the larger business by last-quarter revenue ($846.8M vs $547.7M, roughly 1.5× RadNet, Inc.). Trade Desk (The) runs the higher net margin — 22.1% vs -0.1%, a 22.2% gap on every dollar of revenue. On growth, RadNet, Inc. posted the faster year-over-year revenue change (14.8% vs 14.3%). Over the past eight quarters, Trade Desk (The)'s revenue compounded faster (31.3% CAGR vs 12.6%).

RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.

The Trade Desk, Inc. is an American multinational technology company that specializes in real-time programmatic marketing automation technologies, products, and services, designed to personalize digital content delivery to users.

RDNT vs TTD — Head-to-Head

Bigger by revenue
TTD
TTD
1.5× larger
TTD
$846.8M
$547.7M
RDNT
Growing faster (revenue YoY)
RDNT
RDNT
+0.5% gap
RDNT
14.8%
14.3%
TTD
Higher net margin
TTD
TTD
22.2% more per $
TTD
22.1%
-0.1%
RDNT
Faster 2-yr revenue CAGR
TTD
TTD
Annualised
TTD
31.3%
12.6%
RDNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RDNT
RDNT
TTD
TTD
Revenue
$547.7M
$846.8M
Net Profit
$-597.0K
$186.9M
Gross Margin
80.7%
Operating Margin
5.1%
30.3%
Net Margin
-0.1%
22.1%
Revenue YoY
14.8%
14.3%
Net Profit YoY
-111.2%
2.6%
EPS (diluted)
$0.00
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RDNT
RDNT
TTD
TTD
Q4 25
$547.7M
$846.8M
Q3 25
$522.9M
$739.4M
Q2 25
$498.2M
$694.0M
Q1 25
$471.4M
$616.0M
Q4 24
$477.1M
$741.0M
Q3 24
$461.1M
$628.0M
Q2 24
$459.7M
$584.5M
Q1 24
$431.7M
$491.3M
Net Profit
RDNT
RDNT
TTD
TTD
Q4 25
$-597.0K
$186.9M
Q3 25
$5.4M
$115.5M
Q2 25
$14.5M
$90.1M
Q1 25
$-37.9M
$50.7M
Q4 24
$5.3M
$182.2M
Q3 24
$3.2M
$94.2M
Q2 24
$-3.0M
$85.0M
Q1 24
$-2.8M
$31.7M
Gross Margin
RDNT
RDNT
TTD
TTD
Q4 25
80.7%
Q3 25
78.1%
Q2 25
78.2%
Q1 25
76.8%
Q4 24
81.7%
Q3 24
80.5%
Q2 24
81.1%
Q1 24
78.9%
Operating Margin
RDNT
RDNT
TTD
TTD
Q4 25
5.1%
30.3%
Q3 25
5.2%
21.8%
Q2 25
6.2%
16.8%
Q1 25
-5.1%
8.8%
Q4 24
5.1%
26.4%
Q3 24
7.4%
17.3%
Q2 24
7.6%
16.2%
Q1 24
2.6%
5.8%
Net Margin
RDNT
RDNT
TTD
TTD
Q4 25
-0.1%
22.1%
Q3 25
1.0%
15.6%
Q2 25
2.9%
13.0%
Q1 25
-8.0%
8.2%
Q4 24
1.1%
24.6%
Q3 24
0.7%
15.0%
Q2 24
-0.6%
14.5%
Q1 24
-0.6%
6.4%
EPS (diluted)
RDNT
RDNT
TTD
TTD
Q4 25
$0.00
$0.39
Q3 25
$0.07
$0.23
Q2 25
$0.19
$0.18
Q1 25
$-0.51
$0.10
Q4 24
$0.08
$0.36
Q3 24
$0.04
$0.19
Q2 24
$-0.04
$0.17
Q1 24
$-0.04
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RDNT
RDNT
TTD
TTD
Cash + ST InvestmentsLiquidity on hand
$767.2M
$1.3B
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$1.1B
$2.5B
Total Assets
$3.8B
$6.2B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RDNT
RDNT
TTD
TTD
Q4 25
$767.2M
$1.3B
Q3 25
$804.7M
$1.4B
Q2 25
$833.2M
$1.7B
Q1 25
$717.3M
$1.7B
Q4 24
$740.0M
$1.9B
Q3 24
$748.9M
$1.7B
Q2 24
$741.7M
$1.5B
Q1 24
$527.0M
$1.4B
Total Debt
RDNT
RDNT
TTD
TTD
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$834.6M
Stockholders' Equity
RDNT
RDNT
TTD
TTD
Q4 25
$1.1B
$2.5B
Q3 25
$1.1B
$2.6B
Q2 25
$932.3M
$2.7B
Q1 25
$898.1M
$2.7B
Q4 24
$902.3M
$2.9B
Q3 24
$895.3M
$2.6B
Q2 24
$881.0M
$2.4B
Q1 24
$873.0M
$2.2B
Total Assets
RDNT
RDNT
TTD
TTD
Q4 25
$3.8B
$6.2B
Q3 25
$3.7B
$5.9B
Q2 25
$3.5B
$6.0B
Q1 25
$3.3B
$5.7B
Q4 24
$3.3B
$6.1B
Q3 24
$3.3B
$5.5B
Q2 24
$3.2B
$5.2B
Q1 24
$3.0B
$4.7B
Debt / Equity
RDNT
RDNT
TTD
TTD
Q4 25
1.00×
Q3 25
1.04×
Q2 25
1.18×
Q1 25
1.12×
Q4 24
1.13×
Q3 24
1.14×
Q2 24
1.17×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RDNT
RDNT
TTD
TTD
Operating Cash FlowLast quarter
$84.2M
$311.6M
Free Cash FlowOCF − Capex
$285.3M
FCF MarginFCF / Revenue
33.7%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$795.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RDNT
RDNT
TTD
TTD
Q4 25
$84.2M
$311.6M
Q3 25
$52.8M
$224.7M
Q2 25
$120.3M
$165.0M
Q1 25
$41.5M
$291.4M
Q4 24
$42.5M
$199.4M
Q3 24
$57.4M
$273.3M
Q2 24
$116.0M
$81.3M
Q1 24
$17.1M
$185.5M
Free Cash Flow
RDNT
RDNT
TTD
TTD
Q4 25
$285.3M
Q3 25
$158.3M
Q2 25
$119.8M
Q1 25
$232.3M
Q4 24
$179.2M
Q3 24
$224.6M
Q2 24
$59.1M
Q1 24
$178.2M
FCF Margin
RDNT
RDNT
TTD
TTD
Q4 25
33.7%
Q3 25
21.4%
Q2 25
17.3%
Q1 25
37.7%
Q4 24
24.2%
Q3 24
35.8%
Q2 24
10.1%
Q1 24
36.3%
Capex Intensity
RDNT
RDNT
TTD
TTD
Q4 25
3.1%
Q3 25
9.0%
Q2 25
6.5%
Q1 25
9.6%
Q4 24
2.7%
Q3 24
7.8%
Q2 24
3.8%
Q1 24
1.5%
Cash Conversion
RDNT
RDNT
TTD
TTD
Q4 25
1.67×
Q3 25
9.75×
1.94×
Q2 25
8.33×
1.83×
Q1 25
5.75×
Q4 24
7.96×
1.09×
Q3 24
17.89×
2.90×
Q2 24
0.96×
Q1 24
5.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RDNT
RDNT

Commercial Insurance1$301.0M55%
Medicare1$129.2M24%
Capitation Arrangements$31.9M6%
Health Care Other$20.4M4%
Digital Health$16.4M3%
Other$15.2M3%
Medicaid1$14.0M3%
Workers Compensation Personal Injury1$12.3M2%
Health Care Management Service$7.5M1%

TTD
TTD

Other$427.2M50%
Non Us$419.6M50%

Related Comparisons